A US District Court holds that a drug manufacturer rebates to pharmacy benefits managers (PBM) for exclusive formulary listing do not violate the Sherman Act (Wyeth, J.B.D.L)

A U.S. District Court in Ohio granted summary judgment for defendants in a class action suit alleging that a drug manufacturer's rebates to pharmacy benefit managers in order to obtain an exclusive listing in the PBMs' drug formulary violated Section 1 of the Sherman Act. The plaintiffs,

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

  • Jones Day (Washington DC)

Quotation

Toby G. Singer, A US District Court holds that a drug manufacturer rebates to pharmacy benefits managers (PBM) for exclusive formulary listing do not violate the Sherman Act (Wyeth, J.B.D.L), 13 June 2005, e-Competitions Bulletin Rebates, Art. N° 33846

Visites 819

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues